# Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)

> **NCT00316576** · — · TERMINATED · sponsor: **University Hospital, Caen** · enrollment: 160 (estimated)

## Conditions studied

- Kidney Failure, Acute
- Critical Illness

## Interventions

- **PROCEDURE:** Blood sampling for PCR

## Key facts

- **NCT ID:** NCT00316576
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 160 (ESTIMATED)
- **Why stopped:** The study was stopped on november 2006 after inclusion was fulfilled
- **Last updated:** 2008-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00316576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00316576, "Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00316576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*